Targeting the IL-6/JAK/STAT3 signalling axis in cancer
DE Johnson, RA O'Keefe, JR Grandis - Nature reviews Clinical …, 2018 - nature.com
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
DE Johnson, RA O'Keefe, JR Grandis - Nature reviews. Clinical …, 2018 - europepmc.org
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
[引用][C] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
DE Johnson, RA O'Keefe, JR Grandis - Nature Reviews Clinical …, 2018 - cir.nii.ac.jp
Targeting the IL-6/JAK/STAT3 signalling axis in cancer | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
DE Johnson, RA O'Keefe, JR Grandis - Nature Reviews Clinical …, 2018 - go.gale.com
The IL-6/JAK/STAT3 pathway has a key role in the growth and development of many human
cancers. Elevated levels of IL-6 are observed in chronic inflammatory conditions, such as …
cancers. Elevated levels of IL-6 are observed in chronic inflammatory conditions, such as …
[HTML][HTML] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
DE Johnson, RA O'Keefe… - Nature reviews. Clinical …, 2018 - ncbi.nlm.nih.gov
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
DE Johnson, RA O'Keefe… - Nature reviews. Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer, and such
hyperactivation is generally associated with a poor clinical prognosis. In the tumour …
hyperactivation is generally associated with a poor clinical prognosis. In the tumour …
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
DE Johnson, RA O'Keefe… - Nature Reviews Clinical …, 2018 - escholarship.org
The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer, and such
hyperactivation is generally associated with a poor clinical prognosis. In the tumour …
hyperactivation is generally associated with a poor clinical prognosis. In the tumour …
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
DE Johnson, RA O'Keefe, JR Grandis - Nature reviews. Clinical …, 2018 - europepmc.org
Abstract The IL-6/JAK/STAT3 pathway is aberrantly hyperactivated in many types of cancer,
and such hyperactivation is generally associated with a poor clinical prognosis. In the …
and such hyperactivation is generally associated with a poor clinical prognosis. In the …